In EDS ansehen

Plain language summaries supporting patient involvement: lessons and guidance from HTAi Patient and Citizen Involvement Interest Group (PCIG).

Gespeichert in:
Bibliographische Detailangaben
Titel: Plain language summaries supporting patient involvement: lessons and guidance from HTAi Patient and Citizen Involvement Interest Group (PCIG).
Autoren: Coombes MA; Opened Door Consultancy Limited, Edinburgh, UK., Morgan K; Myeloma Patients Europe, Edinburgh, UK., Diaz J; Bristol Myers Squibb, Uxbridge, UK., Oehrlein EM; Applied Patient Experience, Washington, DC, USA., Andersen H; Bristol Myers Squibb, Melbourne, Australia., Gilardino R; MSD Innovation & Development GmbH, Zurich, Switzerland., Helme K; Novartis Pharmaceuticals, London, UK., Pearce F; Agency for Care Effectiveness, Singapore, Singapore., Cardone A; Cancer Patients Europe, Brussels, Belgium.
Quelle: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2025 Jul 29; Vol. 41 (1), pp. e59. Date of Electronic Publication: 2025 Jul 29.
Publikationsart: Journal Article
Sprache: English
Info zur Zeitschrift: Publisher: Cambridge University Press Country of Publication: England NLM ID: 8508113 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-6348 (Electronic) Linking ISSN: 02664623 NLM ISO Abbreviation: Int J Technol Assess Health Care Subsets: MEDLINE
Imprint Name(s): Original Publication: Cambridge, England ; New York, NY : Cambridge University Press, c1985-
MeSH-Schlagworte: Patient Participation*/methods , Technology Assessment, Biomedical*/organization & administration, Humans ; Australia ; Language ; Community Participation ; England ; Plain Language Summaries
Abstract: Patient involvement is an increasingly recognized cornerstone of effective Health Technology Assessment (HTA). Clear, accessible information empowers patient organizations to contribute meaningfully to HTA. Therefore, an international Summary Information for Patient Groups template was developed to provide plain language summaries of new medicines being assessed. Pilots using the template were conducted in Australia in 2021 and England in 2022, providing a trial within the HTA process. In Australia, the Consumer Evidence and Engagement Unit (CEEU) used a workshop and survey, together with key stakeholder interviews, to gather feedback. In England, the National Institute for Health and Care Excellence used public consultation, surveys, and a Short-Life Working Group (SLWG). An advisory board with patient organizations provided additional insights. The feedback enabled members of the HTA International Patient and Citizen Involvement in HTA Interest Group to evaluate the potential to enhance patient organization submissions to HTA bodies and to provide recommendations on the template's implementation in HTA processes. The pilots highlighted that plain language summaries increased confidence and reduced preparation time for patient organization input to HTA. Other nonexpert stakeholders also found them valuable for fostering understanding. However, challenges remain, including mitigating bias in completed templates, allocating sufficient resources, and integrating into existing processes. The evaluation concludes that the approach holds significant potential to enhance patient organization involvement in HTA. Recommendations include setting up multi-stakeholder SLWGs, ensuring early access to summaries, and aligning implementation with local regulations. These insights provide guidance for HTA bodies to develop an approach to support patient involvement.
References: Front Public Health. 2022 Jul 28;10:922708. (PMID: 35968493)
Front Public Health. 2023 Jul 03;11:1176200. (PMID: 37465169)
Res Involv Engagem. 2017 Jan 10;3:2. (PMID: 29062527)
Int J Technol Assess Health Care. 2020 Jun;36(3):187-190. (PMID: 32398176)
Res Involv Engagem. 2021 Nov 25;7(1):83. (PMID: 34823610)
Int J Technol Assess Health Care. 2021 Apr 01;37(1):e50. (PMID: 33789779)
Int J Technol Assess Health Care. 2021 Jan 13;37:e12. (PMID: 33436125)
Front Med (Lausanne). 2018 Sep 06;5:231. (PMID: 30238004)
Int J Technol Assess Health Care. 2017 Jan;33(6):715-723. (PMID: 29122048)
Contributed Indexing: Keywords: biomedical; patient involvement; plain language summaries; technology assessment
Entry Date(s): Date Created: 20250729 Date Completed: 20250826 Latest Revision: 20250830
Update Code: 20250903
PubMed Central ID: PMC12390740
DOI: 10.1017/S0266462325100408
PMID: 40726106
Datenbank: MEDLINE
Beschreibung
Abstract:Patient involvement is an increasingly recognized cornerstone of effective Health Technology Assessment (HTA). Clear, accessible information empowers patient organizations to contribute meaningfully to HTA. Therefore, an international Summary Information for Patient Groups template was developed to provide plain language summaries of new medicines being assessed. Pilots using the template were conducted in Australia in 2021 and England in 2022, providing a trial within the HTA process. In Australia, the Consumer Evidence and Engagement Unit (CEEU) used a workshop and survey, together with key stakeholder interviews, to gather feedback. In England, the National Institute for Health and Care Excellence used public consultation, surveys, and a Short-Life Working Group (SLWG). An advisory board with patient organizations provided additional insights. The feedback enabled members of the HTA International Patient and Citizen Involvement in HTA Interest Group to evaluate the potential to enhance patient organization submissions to HTA bodies and to provide recommendations on the template's implementation in HTA processes. The pilots highlighted that plain language summaries increased confidence and reduced preparation time for patient organization input to HTA. Other nonexpert stakeholders also found them valuable for fostering understanding. However, challenges remain, including mitigating bias in completed templates, allocating sufficient resources, and integrating into existing processes. The evaluation concludes that the approach holds significant potential to enhance patient organization involvement in HTA. Recommendations include setting up multi-stakeholder SLWGs, ensuring early access to summaries, and aligning implementation with local regulations. These insights provide guidance for HTA bodies to develop an approach to support patient involvement.
ISSN:1471-6348
DOI:10.1017/S0266462325100408